业务新闻

Collaboration Facilitates Continuous Manufacturing – Working together to make a difference

12 Jun 2018

During the recent ACHEMA trade show, which took place in Frankfurt, Germany (11–15 June), GEA hosted a joint press conference with other key suppliers to the pharmaceutical sector to highlight a number of industry collaborations that are helping to facilitate the uptake of continuous manufacturing (CM) technology in the drug production sector.

Achema Press Conference

GEA press-conference on June 12 (from left to right): Albrecht Huber (Leistritz), Dr. Marco Bellentani (MG2), Bart Moors (Siemens), Massimo Bresciani (Research Center Pharmaceutical Engineering, RCPE), Richard Steiner (GEA), Markus Hayek (Accenture), David Lovett (Perceptive Engineering).

Commenting on the event, Phil Gabb, Head of Solid Dosage Sales Support, GEA, said: “All the companies at the press conference have been actively collaborating with providers of complementary technologies and solutions. This is allowing us to deliver the services and infrastructure that our customers need to be able to implement continuous manufacturing.”

“There are several hurdles to negotiate when a company in the pharmaceutical industry decides to adopt continuous manufacturing. And whereas GEA can supply a wide range of process technology solutions, we don’t have the skills or capabilities in every service area to solve all the problems that might arise,” noted Gabb.

The key message, he added, is about companies working together to help the pharmaceutical industry overcome the different challenges involved in adopting continuous manufacturing. The companies involved included

  • Accenture: a leading global professional services company helping pharma clients to shape their strategies around CM and to manage their long-term operations transformation
  • G-CON Manufacturing: designs, produces and installs prefabricated, autonomous cleanroom PODs for the pharmaceutical and biopharmaceutical industries
  • GEA: one of the largest suppliers of process technology to advanced manufacturing industries, and a leader in the development of CM process solution for Solid Dosage Development and Production
  • Leistritz: a developer, manufacturer and marketer of engineered products for the process and pharmaceutical industries
  • MG2: technology leaders in capsule filling
  • Perceptive Engineering: Perceptive Engineering: develops and deploys advanced analytics and intelligent control systems to blue-chip clients around the world
  • RCPE: An international research center specialized in pharmaceutical engineering and predictive science applied to develop mechanistic understanding of products and processes
  • Siemens: world leading provider of digital solutions over the entire value chain and more in particular of PAT Data Management platforms for continuous pharmaceutical manufacturing

"By collaborating with industry peers, we are all leading the way towards smaller, more flexible continuous processing technologies that have the potential to transform the future of pharmaceutical development and manufacturing — and deliver customized quantities of drugs to patients in need in a quick and efficient way," comments Gabb.

“With ConsiGma®, we certainly have a state-of-the-art CM solution and we’re committed to making science work, but we can’t do it all. This collaboration is all about a group of companies who are willing and able to co-operate in a particular area of business for the greater good of the pharmaceutical industry and, above all, the patient.”

For further information about GEA’s processes, products and solutions, contact our experts at gea.com/contact, or via our Facebook page @GEAPharma

Media Relations

GEA Group Aktiengesellschaft

Peter-Müller-Str. 12


40468

Düsseldorf


Germany

+49 211 9136-0

About GEA

GEA 是食品加工行业及众多工业领域的领先供应商之一,2019 年的销售总额约达 49 亿欧元。

作为国际技术集团,我们专注于机械制造,生产运营,工艺技术及其设备组件。 GEA 为各种终端用户市场的复杂生产流程提供可持续的能源解决方案,并提供全面的服务组合。集团在长期持续增长的食品和饮料行业的收入约占其总收入的 70%。截至 2018 年 12 月 31 日,集团的全球员工已超过 18,500 人。GEA 在其业务领域中是市场和技术领导者。GEA 是德国 MDAX 上市公司(G1A,WKN 660 200),拥有 STOXX® Europe 600 指数和优选的 MSCI 全球可持续发展指数。
接收 GEA 新闻

订阅 GEA 的新闻,掌握 GEA 的创新信息和故事。

联系我们

我们随时为您提供帮助!您只需提供少量详细信息,我们就能回复您的查询。